Drug: Bevacizumab Injury: Pyrexia Quarter: 2016Q3
Total Records: 37 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 81331126 | Bevacizumab | Pyrexia | ROCHE | 0.00 | F | 0 | 20160912 | US |
| 82992732 | Bevacizumab | Pyrexia | ROCHE | 69.00 YR | F | 52 KG | 20160929 | US |
| 97046436 | Bevacizumab | Pyrexia | ROCHE | 49.21 YR | F | 77 KG | 20160804 | GB |
| 98832448 | Bevacizumab | Pyrexia | ROCHE | 51.00 YR | F | 37 KG | 20160902 | DE |
| 103377644 | Bevacizumab | Pyrexia | ROCHE | 56.99 YR | F | 62 KG | 20160923 | GB |
| 112724882 | BEVACIZUMAB | Pyrexia | ACTAVIS | 72.63 YR | M | 69 KG | 20160704 | IT |
| 114578486 | Bevacizumab | Pyrexia | ROCHE | 78.49 YR | M | 74 KG | 20160726 | US |
| 118438167 | Bevacizumab | Pyrexia | ROCHE | 60.35 YR | M | 86 KG | 20160826 | GB |
| 122249966 | Bevacizumab | Pyrexia | ROCHE | 74.00 YR | M | 0 | 20160915 | DE |
| 124866344 | Bevacizumab | Pyrexia | ROCHE | 58.46 YR | M | 98 KG | 20160814 | CA |
| 125391301 | BEVACIZUMAB | Pyrexia | ACCORD | 57.00 YR | M | 0 | 20160708 | US |
| 125483631 | BEVACIZUMAB | Pyrexia | MERCK | 0.00 | 0 | 20160712 | US | |
| 125484302 | Bevacizumab | Pyrexia | ROCHE | 83.00 YR | F | 70 KG | 20160916 | US |
| 125789224 | BEVACIZUMAB | Pyrexia | ACTAVIS | 0.00 | M | 0 | 20160810 | GB |
| 125816661 | Bevacizumab | Pyrexia | ROCHE | 32.00 YR | F | 0 | 20160722 | CU |
| 125820362 | BEVACIZUMAB | Pyrexia | MERCK | 0.00 | M | 0 | 20160805 | GB |
| 125859191 | Bevacizumab | Pyrexia | ROCHE | 60.00 YR | F | 0 | 20160725 | NL |
| 126024662 | Bevacizumab | Pyrexia | CIPLA | 0.00 | 0 | 20160812 | GB | |
| 126134182 | BEVACIZUMAB | Pyrexia | GLENMARK | 0.00 | 0 | 20160809 | COUNTRY NOT SPECIFIED | |
| 126151671 | Bevacizumab | Pyrexia | ROCHE | 0.00 | F | 58 KG | 20160802 | FR |
Total Records: 37 Number of Pages: 2